Digital Tool Improves Rural Antibiotic Prescribing Decisions
Catchphrase: An independent evaluation found the Clinical Branches decision-support tool improved guideline-based antibiotic prescribing, although staff turnover and limited awareness restricted its wider adoption.
A digital clinical decision-support tool has improved the quality of antibiotic prescribing within the Western Australian Country Health Service, offering rural and remote doctors greater access to specialist-informed guidance at the point of care.
An independent evaluation conducted by researchers from the University of Technology Sydney found Clinical Branches improved prescribing decisions at hospitals where clinicians adopted the technology.
In those hospitals, prescribing antibiotics in accordance with clinical guidelines improved by almost 21 per cent.
The result is particularly important for regional hospitals and remote health services, where clinicians may not have immediate access to infectious disease specialists, comprehensive pathology services or specialist antimicrobial advice.
Clinical Branches, also known as AMPS, converts conventional therapeutic guidelines into practical, step-by-step clinical pathways. The system considers patient characteristics, available information and local patterns of antimicrobial resistance when presenting guidance.
Rather than requiring clinicians to work through lengthy documents during a consultation, the tool aims to place relevant prescribing information into a structured format that can be followed at the point of care.
UTS senior lecturer in Health Services Management Dr Sarah Wise conducted the evaluation with researchers from the university’s Centre for Health Economics Research and Evaluation and St Vincent’s Hospital Sydney.
“In hospitals where the tool was adopted, the evaluation found an improvement of nearly 21 per cent in prescribing antibiotics according to clinical guidelines,” Dr Wise said.
“In resource-constrained settings where access to specialist advice and timely pathology can be limited, that is a really important step forward.”
Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites change over time and stop responding effectively to medicines. Inappropriate or unnecessary antimicrobial use can accelerate the development of resistant organisms, making infections more difficult to treat.
Dr Wise described antimicrobial resistance as the “sleeping giant” of public health.
“It doesn’t always get the research and scientific attention it deserves, but is an ongoing challenge, particularly for vulnerable rural and remote populations already facing health inequities, including areas with high Aboriginal and Torres Strait Islander populations,” she said.
“We’re not getting enough new antibiotics to keep up with resistant strains, so we have to make the very best use of the antibiotics we already have.”
That makes antimicrobial stewardship increasingly important. Stewardship involves choosing an appropriate medicine only when needed, using a suitable dose and treatment duration, and reviewing therapy as clinical or pathology information becomes available.
WA Country Health Service chief pharmacist Jonathan Nugent said Clinical Branches helped reduce the disadvantage created by limited access to specialist antimicrobial advice.
“It provides timely, specialist-informed and locally relevant guidance at the point of care, supporting safe and appropriate prescribing,” Mr Nugent said.
“What makes it particularly valuable is that the guidance is tailored to where you’re working.”
However, the evaluation also identified practical barriers to broader adoption. Limited awareness of the tool, workforce turnover, onboarding requirements and access issues reduced consistent use across participating services.
These challenges are particularly relevant in rural and remote health settings, where workforces can change frequently and clinicians may need to navigate several different digital systems.
Clinical Branches was developed by Australian healthcare software company Kraken Coding. The company specialises in AI-supported clinical decision tools.
Kraken Coding co-founder John Shanks said rural clinicians regularly made complex antimicrobial decisions without a specialist nearby.
“UTS showed us what adoption takes: clinicians trusted the tool, and the gaps were awareness, onboarding and access, which gives us a clear plan,” Mr Shanks said.
Because the clinical pathways operate as “living guidelines”, they can be updated to reflect new evidence and changing local resistance patterns.
Mr Shanks said the company was now applying the same decision-support approach to other areas of remote healthcare.
The evaluation suggests digital tools can improve antibiotic prescribing when clinicians know how to access them and incorporate them into everyday practice. However, technology alone is not enough. Successful implementation also requires effective training, reliable access, workforce onboarding and continuing organisational support.

